|Transforming growth factor-β signalling: role and consequences of Smad linker region phosphorylation|
D Kamato, ML Burch, TJ Piva, HB Rezaei, MA Rostam, S Xu, W Zheng, ...
Cellular signalling 25 (10), 2017-2024, 2013
|Gaq proteins: molecular pharmacology and therapeutic potential|
D Kamato, P Mitra, F Davis, N Osman, R Chaplin, PJ Cabot, R Afroz, ...
Cellular and Molecular Life Sciences 74 (8), 1379-1390, 2017
|The role of specific Smad linker region phosphorylation in TGF-β mediated expression of glycosaminoglycan synthesizing enzymes in vascular smooth muscle|
MA Rostam, D Kamato, TJ Piva, W Zheng, PJ Little, N Osman
Cellular Signalling 28 (8), 956-966, 2016
|Cell biology of Smad2/3 linker region phosphorylation in vascular smooth muscle|
HB Rezaei, D Kamato, G Ansari, N Osman, PJ Little
Clinical and Experimental Pharmacology and Physiology 39 (8), 661-667, 2012
|Animal models for assessing the impact of natural products on the aetiology and metabolic pathophysiology of Type 2 diabetes|
M Asrafuzzaman, Y Cao, R Afroz, D Kamato, S Gray, PJ Little
Biomedicine & Pharmacotherapy 89, 1242-1251, 2017
|Structure, function, pharmacology, and therapeutic potential of the G protein, Gα/q, 11|
D Kamato, L Thach, R Bernard, V Chan, W Zheng, H Kaur, M Brimble, ...
Frontiers in cardiovascular medicine 2, 14, 2015
|The expansion of GPCR transactivation-dependent signalling to include serine/threonine kinase receptors represents a new cell signalling frontier|
D Kamato, MA Rostam, R Bernard, TJ Piva, N Mantri, D Guidone, ...
Cellular and Molecular Life Sciences 72 (4), 799-808, 2015
|Endothelial function and dysfunction: Impact of metformin|
A Nafisa, SG Gray, Y Cao, T Wang, S Xu, FH Wattoo, M Barras, N Cohen, ...
Pharmacology & therapeutics 192, 150-162, 2018
|Transforming growth factor β‐mediated site‐specific S mad linker region phosphorylation in vascular endothelial cells|
D Kamato, MA Rostam, TJ Piva, H Babaahmadi Rezaei, R Getachew, ...
Journal of Pharmacy and Pharmacology 66 (12), 1722-1733, 2014
|Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics|
S Xu, D Kamato, PJ Little, S Nakagawa, J Pelisek, ZG Jin
Pharmacology & therapeutics 196, 15-43, 2019
|Therapeutic implications of endothelin and thrombin G‐protein‐coupled receptor transactivation of tyrosine and serine/threonine kinase cell surface receptors|
D Kamato, ML Burch, N Osman, W Zheng, PJ Little
Journal of Pharmacy and Pharmacology 65 (4), 465-473, 2013
|Protease activated receptor-1 mediated dual kinase receptor transactivation stimulates the expression of glycosaminoglycan synthesizing genes|
D Kamato, L Thach, R Getachew, M Burch, MD Hollenberg, W Zheng, ...
Cellular signalling 28 (1), 110-119, 2016
|(S)‐‐Gingerol inhibits TGF‐β‐stimulated biglycan synthesis but not glycosaminoglycan hyperelongation in human vascular smooth muscle cells|
D Kamato, H Babaahmadi Rezaei, R Getachew, L Thach, D Guidone, ...
Journal of Pharmacy and Pharmacology 65 (7), 1026-1036, 2013
|Peptidyl‐prolyl isomerases: Functionality and potential therapeutic targets in cardiovascular disease|
MA Rostam, TJ Piva, HB Rezaei, D Kamato, PJ Little, W Zheng, N Osman
Clinical and Experimental Pharmacology and Physiology 42 (2), 117-124, 2015
|Thrombin promotes PAI-1 expression and migration in keratinocytes via ERK dependent Smad linker region phosphorylation|
N Talati, D Kamato, TJ Piva, PJ Little, N Osman
Cellular Signalling 47, 37-43, 2018
|Suramin inhibits PDGF‐stimulated receptor phosphorylation, proteoglycan synthesis and glycosaminoglycan hyperelongation in human vascular smooth muscle cells|
PJ Little, MA Rostam, TJ Piva, R Getachew, D Kamato, D Guidone, ...
Journal of Pharmacy and Pharmacology 65 (7), 1055-1063, 2013
|Insights into cellular signalling by G protein coupled receptor transactivation of cell surface protein kinase receptors|
R Chaplin, L Thach, MD Hollenberg, Y Cao, PJ Little, D Kamato
Journal of cell communication and signaling 11 (2), 117-125, 2017
|Signalling pathways regulating galactosaminoglycan synthesis and structure in vascular smooth muscle: implications for lipoprotein binding and atherosclerosis|
R Afroz, Y Cao, MA Rostam, H Ta, S Xu, W Zheng, N Osman, D Kamato, ...
Pharmacology & therapeutics 187, 88-97, 2018
|Flavopiridol inhibits TGF-β-stimulated biglycan synthesis by blocking linker region phosphorylation and nuclear translocation of Smad2|
MA Rostam, A Shajimoon, D Kamato, P Mitra, TJ Piva, R Getachew, ...
Journal of Pharmacology and Experimental Therapeutics 365 (1), 156-164, 2018
|Endothelin‐1 (ET‐1) stimulates carboxy terminal Smad2 phosphorylation in vascular endothelial cells by a mechanism dependent on ET receptors and de novo protein synthesis|
N Sharifat, G Mohammad Zadeh, MA Ghaffari, P Dayati, D Kamato, ...
Journal of Pharmacy and Pharmacology 69 (1), 66-72, 2017